• California: Cue Health on May 20 announced in a WARN notice filed with California state regulators that it will be laying off all employees and shutting down as of May 24. Cue Health rose to prominence during the COVID-19 pandemic, creating one of the only molecular at-home COVID-19 tests. However, earlier this month, FDA warned consumers not to use Cue's COVID-19 test kits as they could produce false results. Over the past 18 months, Cue has gone through five rounds of layoffs. Following FDA's warning letter, the company announced that it wouldn't be filing its quarterly earnings and that co-founder and former CEO Ayub Khattak would be leaving the company's board of directors. In the WARN notice, Cue's chief human resources officer Allison Blackwell said that all U.S. employees who had not already received a termination notice would be receiving one, and all employees would receive their final paychecks on May 24. (Trang, STAT+ [subscription required], 5/22)
• Missouri: Express Scripts on Thursday announced its partnership with pharmacy network CPESN USA, which comprises 3,500 pharmacies in 44 states, in an effort to improve care delivery. The partnership will focus first on Medicare enrollees with hypertension and diabetes. According to Express Scripts, the companies intend to expand their partnership, though they didn't provide details on what the expansion would look like, the timeline of the partnership, or the financial terms. (Berryman, Modern Healthcare, 5/23)
• New Jersey: FDA issued a briefing document showing that late-stage trial data found that patients with Type 1 diabetes who took Novo Nordisk's long-acting insulin after a year had 50% to 80% more clinically significant or severe hypoglycemia than those who took Novo's daily insulin and did not offer better management of sugar levels or other benefits. FDA found the period of highest risk occurred within two to four days after receiving the injection and coincided with the peak glucose-lowering effect of the shot. (Bettelheim, Axios, 5/23)

Regional health plans are facing increased competition from national insurers and rising demands from consumers. Learn how regional plans can effectively respond to market forces and drive growth through diversification with three actionable strategies and real-world examples.